International Flavors & Fragrances

Produces flavors, fragrances, and pharma solutions.

International Flavors & Fragrances

Produces flavors, fragrances, and pharma solutions.

Overview

International Flavors & Fragrances Inc. operates as a vertically integrated supplier of ingredients and formulations across four main areas: Nourish (food and beverage ingredients and solutions), Health & Biosciences (sustainable, bio-based solutions), Scent (fragrances for fine perfumery, personal care, and home care), and Pharma Solutions (functional excipients and active pharmaceutical ingredients for pharma and dietary supplements). Its products go from research and development through manufacturing, enabling customers to formulate foods, cosmetics, and medicines. The company differentiates itself by concentrating resources on higher-margin segments (Scent, Nourish flavors, Health & Biosciences) and by streamlining its portfolio through strategic divestitures to improve margins and return on invested capital. The overarching goal is steady margin expansion and stronger ROIC while delivering integrated, end-to-end solutions to its global customer base.

Work here?Claim your company

About International Flavors & Fragrances

Simplify's Rating

Why International Flavors & Fragrances is rated

B-

Rated B on Competitive Edge

Rated B on Growth Potential

Rated C on Differentiation

Industries

Food & AgricultureBiotechnologyHealthcareConsumer Goods

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1889

Get referred to International Flavors & Fragrances

See people who can refer or advise you

Simplify's take

What believers are saying

IFF raised 2026 sales guidance to $7.5-$7.6 billion after strong Q3 on November 3.
Q3 2026 adjusted operating EBITDA reached $403 million, with Taste and Scent growing 6% each.
The $4.3 billion Food Ingredients sale to CVC closes by end-2Q27, lowering leverage and complexity.

What critics are saying

Health & Biosciences faces weaker supplement demand and higher costs into Q4 2026.
Food Ingredients separation remains unfinished; stranded costs and execution risk run through mid-2027.
Raw-material inflation and pricing lag could compress margins in first-quarter 2027, hurting cash flow.

What makes International Flavors & Fragrances unique

IFF’s 2026 pipeline spans Taste, Scent, and Health, backed by deep formulation R&D.
SENSORA launched June 30, 2026, strengthening IFF’s patent-pending, water-based fragrance technology moat.
HOWARU GutABAlite launched October 28, 2026, linking probiotics, metabolic health, and clinical evidence.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1B

Above

Industry Average

Funded Over

2 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!

Post IPO Debt Funding Comparison Coming Soon

Benefits

Health Insurance
Dental Insurance
401(k) Company Match
Paid Vacation
Performance Bonus

Stock Price

Company News

Yahoo Finance

Nov 8th, 2026

BofA downgrades IFF to Underperform, cuts price target to $91 on margin pressure

BofA has cut International Flavors & Fragrances (IFF) to Underperform from Buy and lowered its price target to $91 from $95. The downgrade came on November 6. The bank said the shares have risen substantially and lack near-term catalysts. It also pointed to softness in businesses outside Taste, and expects raw material inflation of about 3% to limit operating leverage into the first half of 2027. The third quarter was strong, however. Net sales rose 4% to $1.94 billion, and adjusted operating EBITDA of $403 million beat BofA's estimate of $398 million. IFF raised the low end of its 2026 sales outlook to $7.5 billion to $7.6 billion. IFF has a market cap of $20.69 billion.

The Markets Daily

Nov 8th, 2026

International Flavors & Fragrances Q3 earnings call highlights.

International Flavors & Fragrances Q3 earnings call highlights. International Flavors & Fragrances (NYSE:IFF) raised the lower ends of its 2026 sales and earnings guidance after third-quarter growth across all three continuing business segments, though executives warned that a weak health market and higher costs would weigh on fourth-quarter profitability. The company generated revenue of just under $2 billion in the third quarter, up approximately 5% on a comparable currency-neutral basis. Adjusted operating EBITDA rose 6% to $403 million, while the corresponding margin expanded 20 basis points to 20.8%, Chief Financial Officer Michael DeVeau said. Chief Executive Officer Erik Fyrwald attributed the company's year-to-date progress to volume growth and productivity. He said the revised outlook also incorporates near-term profitability softness, particularly in Health & Biosciences. IFF generally discussed sales and EBITDA growth on a comparable currency-neutral basis. Its results and guidance reflect continuing operations following the announced Food Ingredients divestiture, while cash flow, capital spending and leverage figures include discontinued operations. Taste and scent lead quarterly growth. Taste sales increased 6% to $687 million, with growth across all regions. Greater Asia led with a double-digit increase, followed by high-single-digit growth in Latin America. Segment EBITDA rose 7% to $128 million, driven by volume. Scent sales also grew 6%, reaching $689 million, while EBITDA increased 10% to $139 million. Consumer Fragrances posted high-single-digit growth, and Fine Fragrance and Fragrance Ingredients each grew by mid-single digits. Fyrwald said Fine Fragrance benefited from new business wins in Europe and North America, while demand in the Middle East had stabilized with some signs of growth. He cautioned, however, that geopolitical instability made the region's outlook uncertain. Health & Biosciences sales rose 1% to $566 million, as mid-single-digit growth in Food Biosciences and Grain Processing more than offset a decline in health. The segment's EBITDA increased 2% to $139 million. Fyrwald said consumers in the U.S. and Europe had reduced spending on dietary supplements amid economic pressure. IFF is responding by strengthening its commercial capabilities, diversifying its customer base and expanding its innovation pipeline, he said. Outlook reflects cost pressures. IFF now expects full-year sales of $7.5 billion to $7.6 billion and adjusted operating EBITDA of $1.55 billion to $1.6 billion. DeVeau said fourth-quarter sales growth was expected to be around 3%, plus or minus, and that the company did not see material customer inventory management at the time of the call. Fourth-quarter profit margins are expected to decline sequentially, partly because of seasonal factors and partly because of higher costs and investments, particularly in Health & Biosciences. DeVeau identified softer volume in the higher-margin health business, unfavorable pricing relative to input costs, and the timing of research and commercial investments as the main pressures on that segment. Across IFF's continuing operations, the largest cost increases are tied to oil derivatives, energy and logistics, DeVeau said. Asked about a peer's expectation for 3% raw-material inflation in 2027, he said it was early to comment but that the figure was consistent with current trends. IFF is discussing pricing with customers and working on productivity to recover higher costs. DeVeau said the gap between pricing and input costs is expected to be greatest in the first quarter of 2027 before improving through the year. Divestiture and capital allocation. IFF remains on track to close its approximately $4.3 billion sale of Food Ingredients to CVC Capital Partners by the end of the first half of 2027, Fyrwald said. The company has also completed the sale of its Soy Crush, Concentrates and Lecithin business and expects other agreed divestitures to close by year-end. DeVeau said IFF is working to eliminate about two-thirds of the approximately $100 million in stranded costs associated with the Food Ingredients separation within 12 months of closing. Actions include renegotiating third-party contracts, using shared services and technology, and adjusting the organization's structure. For the first nine months of 2026, free cash flow was $371 million, an increase of $245 million from a year earlier. IFF also completed a $500 million accelerated share repurchase, buying approximately 5.8 million shares, and does not plan additional repurchases in the fourth quarter, DeVeau said. Net debt to credit-adjusted EBITDA stood at 2.75 times at the end of the third quarter. DeVeau said the increase reflected short-term debt used to fund the accelerated repurchase, which IFF expects to repay with proceeds from the Food Ingredients sale. About international Flavors & Fragrances (NYSE:IFF). International Flavors & Fragrances Inc (NYSE: IFF) develops ingredients and solutions used by manufacturers in food and beverages, fragrances, personal care, home care, health and wellness, and other consumer products. Its offerings include flavors, fragrance compounds, enzymes, cultures, probiotics, and specialty food ingredients. The company works with customers to create and improve products, including by enhancing taste and scent, supporting product performance, and developing ingredients for nutrition and wellness applications.

Daily Political

Nov 5th, 2026

International Flavors & Fragrances (NYSE:IFF) stock price target raised at UBS Group.

International Flavors & Fragrances (NYSE:IFF) stock price target raised at UBS Group. International Flavors & Fragrances (NYSE:IFF - Get Free Report) had its price target raised by analysts at UBS Group from $91.00 to $95.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a "neutral" rating on the specialty chemicals company's stock. UBS Group's price objective points to a potential upside of 9.78% from the stock's previous close. Several other equities research analysts have also recently weighed in on IFF. Wall Street Zen upgraded International Flavors & Fragrances from a "sell" rating to a "hold" rating in a research note on Sunday, October 25th. JPMorgan Chase & Co. increased their price target on shares of International Flavors & Fragrances from $92.00 to $95.00 and gave the company an "overweight" rating in a research note on Thursday. Vertical Research cut shares of International Flavors & Fragrances from a "buy" rating to a "hold" rating and set a $93.00 price objective on the stock. in a report on Thursday, August 6th. Barclays boosted their price objective on shares of International Flavors & Fragrances from $96.00 to $105.00 and gave the stock an "overweight" rating in a research report on Friday, October 16th. Finally, Benchmark upped their target price on shares of International Flavors & Fragrances from $100.00 to $105.00 and gave the company a "buy" rating in a report on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $94.99. International Flavors & Fragrances stock down 1.3%. NYSE:IFF traded down $1.13 during trading hours on Thursday, hitting $86.54. The company's stock had a trading volume of 3,518,160 shares, compared to its average volume of 1,874,557. The stock has a market capitalization of $22.08 billion, a P/E ratio of 121.88, a price-to-earnings-growth ratio of 3.96 and a beta of 0.86. The stock has a fifty day moving average of $87.19 and a 200-day moving average of $78.85. The company has a current ratio of 2.06, a quick ratio of 1.72 and a debt-to-equity ratio of 0.34. International Flavors & Fragrances has a 52-week low of $61.72 and a 52-week high of $95.27. International Flavors & Fragrances (NYSE:IFF - Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The specialty chemicals company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.02. The company had revenue of $1.94 billion during the quarter, compared to the consensus estimate of $1.91 billion. International Flavors & Fragrances had a return on equity of 6.72% and a net margin of 1.97%. International Flavors & Fragrances's revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.05 EPS. On average, equities analysts forecast that International Flavors & Fragrances will post 3.24 earnings per share for the current year. International Flavors & Fragrances announced that its board has authorized a stock buyback plan on Tuesday, August 4th that permits the company to repurchase $2.50 billion in shares. This repurchase authorization permits the specialty chemicals company to repurchase up to 12.1% of its stock through open market purchases. Share repurchase plans are generally a sign that the company's board believes its stock is undervalued. Insider transactions at International Flavors & Fragrances. In other International Flavors & Fragrances news, insider De Mendonca Ana Paula Teles sold 5,718 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $83.19, for a total value of $475,680.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Marc Birenkrant sold 1,000 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $85.00, for a total value of $85,000.00. Following the completion of the sale, the chief accounting officer directly owned 3,446 shares of the company's stock, valued at $292,910. The trade was a 22.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.07% of the stock is owned by corporate insiders. Hedge funds weigh in on International Flavors & Fragrances. Institutional investors have recently modified their holdings of the business. Studio Investment Management LLC grew its position in International Flavors & Fragrances by 3.7% during the 2nd quarter. Studio Investment Management LLC now owns 3,916 shares of the specialty chemicals company's stock worth $312,000 after purchasing an additional 138 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of International Flavors & Fragrances by 27.9% in the second quarter. Parkside Financial Bank & Trust now owns 706 shares of the specialty chemicals company's stock valued at $56,000 after buying an additional 154 shares during the last quarter. Waverly Advisors LLC boosted its stake in shares of International Flavors & Fragrances by 4.2% during the second quarter. Waverly Advisors LLC now owns 3,850 shares of the specialty chemicals company's stock worth $305,000 after buying an additional 156 shares during the period. HB Wealth Management LLC boosted its stake in shares of International Flavors & Fragrances by 2.8% during the second quarter. HB Wealth Management LLC now owns 6,272 shares of the specialty chemicals company's stock worth $497,000 after buying an additional 171 shares during the period. Finally, Chicago Partners Investment Group LLC grew its holdings in shares of International Flavors & Fragrances by 2.5% during the third quarter. Chicago Partners Investment Group LLC now owns 8,473 shares of the specialty chemicals company's stock worth $798,000 after buying an additional 207 shares during the last quarter. 96.02% of the stock is owned by institutional investors and hedge funds. Key headlines impacting International Flavors & Fragrances. Here are the key news stories impacting International Flavors & Fragrances this week: * Analysts raised their targets. JPMorgan lifted its target to $95 and kept an overweight rating, while Citigroup raised its target to $105 and maintained a buy rating. * Q3 adjusted results topped estimates. IFF reported adjusted EPS of $0.83 versus the $0.81 consensus, and sales also exceeded expectations, with strength in Taste and Scent. The company also raised its 2026 guidance. * Guidance and costs remain a concern. Despite the guidance increase, reports characterized the outlook as soft and flagged a Q4 profit warning. Rising costs could weigh on profitability, helping explain why the earnings beat has not fully reassured investors. International Flavors & Fragrances company profile. International Flavors & Fragrances Inc (NYSE:IFF) develops and manufactures ingredients, flavor systems, fragrances and specialty solutions used in consumer and industrial products. Its offerings support food and beverage manufacturers, fragrance and personal care companies, household-product makers, pharmaceutical businesses and other customers. The company's portfolio includes flavors for beverages, dairy products, sweet goods, savory foods and other applications; fragrances for fine fragrance, personal care and home care products; and functional ingredients, enzymes, cultures, natural extracts and other specialty materials. Further reading. Receive News & Ratings for International Flavors & Fragrances Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Flavors & Fragrances and related companies with MarketBeat.com's FREE daily email newsletter.

Food Ingredients First

Nov 4th, 2026

IFF Taste sales climb 6% as Greater Asia drives Q3 growth.

IFF Taste sales climb 6% as Greater Asia drives Q3 growth. Key takeaways. * Double-digit growth in Greater Asia drives a 6% increase in Taste sales on a comparable, currency-neutral basis. * Growth in Food Biosciences and Grain Processing offsets weaker Health performance. * IFF raises its full-year outlook as its Food Ingredients divestiture remains on track for Q2 2027. The Taste business of International Flavors & Fragrances (IFF) recorded growth across all regions in the third quarter of 2026, led by a double-digit year-over-year sales increase in Greater Asia on a comparable, currency-neutral basis. Taste sales reached US$687 million in the quarter ended September 30, up 4% as reported and 6% on a comparable, currency-neutral basis. Adjusted operating EBITDA totaled US$128 million, with an 18.6% margin. On a comparable, currency-neutral basis, adjusted operating EBITDA increased 7%, driven by volume growth. "Volumes remain solid as customers continue to value our strong R&D and innovation," says IFF CEO Erik Fyrwald. Food Biosciences offsets Health weakness. On a comparable, currency-neutral basis, Food Biosciences and Grain Processing posted mid-single-digit growth, more than offsetting a decline in Health. Divisional sales reached US$566 million, up 1% from the same period last year. Adjusted operating EBITDA totaled US$136 million, with a 24% margin. Comparable, currency-neutral adjusted operating EBITDA rose 2%, with volume growth and favorable pricing relative to input costs contributing equally. Ingredients separation on track. IFF says the Food Ingredients divestiture remains on schedule to close by the end of Q2 2027. The results cover continuing operations, excluding the Food Ingredients disposal group and the Soy Crush, Concentrates, and Lecithin businesses, which are classified as discontinued operations. Higher outlook, softer fourth quarter. Sales from continuing operations rose 4% year-over-year to US$1.94 billion in the third quarter ended September 30, 2026. Adjusted operating EBITDA reached US$403 million, while the company recorded a reported pretax loss of US$134 million. IFF raised the lower end of its full-year sales forecast to US$7.5 billion, up from US$7.4 billion, while maintaining the upper end at US$7.6 billion. It now expects full-year adjusted operating EBITDA of US$1.55-1.60 billion, compared with the US$1.53-1.60 billion forecast issued in August. Comparable, currency-neutral sales growth is forecast at 3-4%, versus 2-4% previously. Despite the improved outlook, IFF expects softer fourth-quarter profitability, particularly in Health & Biosciences, reflecting higher costs and reinvestment to strengthen the business.

Yahoo Finance

Nov 3rd, 2026

IFF shares fall 3% as 2026 revenue guidance of $7.5B–$7.6B trails estimates despite Q3 beat

International Flavors & Fragrances (IFF) shares fell 3% in after-hours trading on Tuesday, even though third-quarter results beat expectations. Investors were disappointed by the company's full-year 2026 guidance. Adjusted earnings per share were $0.83, against the $0.81 consensus. Revenue rose 4% to $1.94 billion, above the $1.91 billion estimate. Adjusted operating EBITDA was $403 million. IFF raised the low end of its 2026 revenue guidance to $7.5 billion–$7.6 billion. The $7.55 billion midpoint is below the analyst consensus of $7.589 billion. The company expects softer fourth-quarter profitability, particularly in Health & Biosciences, because of higher costs and reinvestment.

Recently Posted Jobs